Aripiprazole Tablets USP — Class II drug recall D-0594-2026
Ongoing recall by Ajanta Pharma USA Inc, reported 2026-06-24, distributed nationwide. Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Ta
| Recall number | D-0594-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Ajanta Pharma USA Inc, Bridgewater, NJ, United States |
| Recall initiated | 2026-05-27 |
| Classified | 2026-06-16 |
| Reported by FDA | 2026-06-24 |
| Distributed | Nationwide (US) |
| Quantity | 6,143 bottles |
| NDC | 27241-0051, 27241-0051-03, 27241-0051-08, 27241-0052, 27241-0052-03, 27241-0052-08, 27241-0053, 27241-0053-03, 27241-0053-08, 27241-0054, 27241-0054-03, 27241-0054-08, 27241-0055, 27241-0055-03, 27241-0055-08, 27241-0056, 27241-0056-03, 27241-0056-08 |
| Lot numbers | PA00805 |
| Expiration dates | 2029-01-31 |
Product
Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-056-03.
Reason for recall
Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0594-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.